By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cephalon, Inc. 

Corporate Headquarters
41 Moores Road
Frazer  Pennsylvania  19355  U.S.A.
Phone: 610-344-0200 Fax: 610-344-0981



Bristol-Myers Squibb Pharmaceutical Research Institute  Stadol NS® for pain management and Serzone® (nefazodone hydrochloride) for depression

LEO Pharma China 

TAP Holdings 

Company News
European Commission (EC) Accuses Teva (TEVA), Cephalon (CEPH) of Anti-Competitive Behavior 7/17/2017 6:04:08 AM
Cephalon (CEPH), U.S. States Reach $125 Million Settlement Over Generic Drugs 8/5/2016 7:02:29 AM
Cephalon (CEPH)’s Narcolepsy Drug Modafinil May Be World’s First Safe ‘Smart Drug,’ Study Says 8/21/2015 6:58:30 AM
FTC Settlement Of Cephalon, Inc. (CEPH) Pay For Delay Case Ensures $1.2 Billion In Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 5/28/2015 9:07:11 AM
Teva Pharmaceutical Industries Limited (TEVA)'s Cephalon, Inc. (CEPH) Accused of Fraud by Whistleblower 3/21/2013 8:00:08 AM
Myriad Genetics, Inc. (MYGN) and Cephalon, Inc. (CEPH) Enter Into Companion Diagnostic Agreement 3/29/2012 10:09:55 AM
Stemline Therapeutics, Inc. Appoints Kevin Buchi, Former CEO of Cephalon, Inc. (CEPH), to Its Board of Directors 3/15/2012 6:42:06 AM
Cephalon, Inc. (CEPH) Drama Topped Several Major Health-Care Deals 3/2/2012 8:44:20 AM
Teva Pharmaceutical Industries Limited (TEVA)'s Cephalon, Inc. (CEPH) Recalls Treanda Leukemia Drug Due to Glass Fragments 1/30/2012 8:10:45 AM
Teva Pharmaceutical Industries Limited (TEVA) Dismisses Media Reports of Layoff After Cephalon, Inc. (CEPH) Buyout 11/10/2011 8:16:52 AM